Kindling Bio
PrivateLast Round
Grant
Dec 3, 2025
Total Funding Raised
$428,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Kindling Bio operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Grant round in December 2025.
Kindling Bio is a biotechnology company that develops pediatric-led, next-generation cancer gene therapies designed to reprogram tumor biology and harness children's immune responses to fight a wide range of tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kindling Bio Comparables
Compare Kindling Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BrainChild Bio, Inc. | 79% | |
| Spes Immunotherapeutics | 71% | |
| Immugenia Inc. | 71% |
For institutional investors. Book with your work email.
Kindling Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 3, 2025 | ||||
| Seed | Oct 1, 2025 |
For institutional investors. Book with your work email.
Kindling Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deep Science Ventures | Seed |
| Innovate UK | Seed |
| Paris-Saclay Cancer Cluster | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 3, 2025
$108K raised from Paris-Saclay Cancer Cluster
- Oct 1, 2025
$320K round with Deep Science Ventures and Innovate UK
For institutional investors. Book with your work email.
Kindling Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kindling Bio's valuation, stock price, and market status.
Is Kindling Bio a public or private company?
Kindling Bio is a private company.
What is the current stock price of Kindling Bio?
Kindling Bio is a private company, so its shares have no public market price. Caplight tracks Kindling Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kindling Bio worth (valuation)?
Valuation information for Kindling Bio is not publicly available.
Can I buy Kindling Bio stock?
Kindling Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kindling Bio's last funding round?
Kindling Bio's most recent funding round was Grant on December 3, 2025.
Who are the main investors in Kindling Bio?
Key investors in Kindling Bio include Deep Science Ventures, Innovate UK, Paris-Saclay Cancer Cluster.
Will Kindling Bio IPO soon?
No public IPO plans have been announced for Kindling Bio.
How can I track Kindling Bio secondary market activity?
Caplight tracks bids, offers, and trades in Kindling Bio's shares on secondary markets.